The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
Saved in:
| Title: | The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells. |
|---|---|
| Authors: | Golay, J.1, Cuppini, L.1, Leoni, F.2, Micò, C.1, Barbui, V.1, Domenghini, M.1, Lombardi, L.3, Neri, A.3, Barbui, A. M.1, Salvi, A.1, Pozzi, P.2, Porro, G.2, Pagani, P.2, Fossati, G.2, Mascagni, P.2, Introna, M.1, Rambaldi, A.1 arambaldi@ospedaliriuniti.bergamo.it |
| Source: | Leukemia (08876924). Sep2007, Vol. 21 Issue 9, p1892-1900. 9p. 1 Chart, 7 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
